Breaking News Instant updates and real-time market news.

ARNA

Arena Pharmaceuticals

$39.75

8.86 (28.68%)

16:02
03/20/18
03/20
16:02
03/20/18
16:02

Arena Pharmaceuticals files to sell 7.5M shares of common stock

Citigroup and Leerink Partners are acting as joint book-running managers for the offering. Cantor, Credit Suisse and RBC Capital Markets are also acting as joint book-running managers. Guggenheim Securities and JMP Securities are acting as co-managers for the offering.

ARNA Arena Pharmaceuticals
$39.75

8.86 (28.68%)

03/20/18
WELS
03/20/18
NO CHANGE
Target $60
WELS
Outperform
Arena Pharmaceuticals price target raised to $60 from $53 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Arena Pharmaceuticals to $60 form $53 following positive OASIS phase 2 data for etrasimod in ulcerative colitis. The analyst reiterates an Outperform rating on the shares.
03/20/18
NEED
03/20/18
UPGRADE
Target $60
NEED
Buy
Arena Pharmaceuticals upgraded to Buy at Needham on phase 2 UC data
As reported earlier, Needham analyst Alan Carr upgraded Arena Pharmaceuticals to Buy from Hold with a price target of $60. Carr cites the company's "impressive results" from its Phase 2 Ulcerative Colitis study unveiled yesterday, noting that the the safety and tolerability data components are also "encouraging". The analyst adds that the favorable outcome warrants an update to his pricing model, particularly in light of "substantial" unmet need in the Inflammation space where there are few S1P modulators currently in development.
03/20/18
JMPS
03/20/18
NO CHANGE
Target $79
JMPS
Outperform
Arena Pharmaceuticals price target raised to $79 from $63 at JMP Securities
JMP Securities analyst Jason Butler said Arena Pharmaceuticals' top-line results for etrasimod in ulcerative colitis meet or beat his best-case expectations and he has increased his view of the probability of success for etrasimod in UC to 75% from 50% following the report of the data. Given the higher odds he places on the success of the drug in that indication, Butler raised his price target on Arena shares to $79 from $63 and keeps an Outperform rating on the stock.
03/20/18
03/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Universal Display (OLED) upgraded to Buy from Hold at Gabelli with analyst Hendi Susanto saying he views the negative market response to a Bloomberg report that Apple (AAPL) is designing and producing MicroLED display prototypes as an overreaction and a buying opportunity. 2. Oneok (OKE) upgraded to Buy from Hold at Jefferies with analyst Christopher Sighinolfi saying he is confident in Oneok's ability to hit target returns on $4.2B of its current projects following a recent meeting with management. 3. PPG (PPG) upgraded to Buy from Hold at Deutsche Bank with analyst David Begleiter saying he believes the company's capital deployment and "valuation discount" are attractive. 4. Roku (ROKU) upgraded to Perform from Underperform at Oppenheimer with analyst Jason Helfstein upgraded Roku (ROKU) to Perform citing valuation and the company's opportunity in virtual multichannel video programming distribution. 5. Arena Pharmaceuticals (ARNA) upgraded to Buy from Hold at Needham with analyst Alan Carr citing the company's "impressive results" from its Phase 2 Ulcerative Colitis study, noting that the the safety and tolerability data components are also "encouraging." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ADBE

Adobe

$242.33

-6.56 (-2.64%)

11:55
10/15/18
10/15
11:55
10/15/18
11:55
Conference/Events
Adobe to hold a conference »

Adobe MAX is being held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

KRYS

Krystal Biotech

$19.73

4.24 (27.37%)

11:52
10/15/18
10/15
11:52
10/15/18
11:52
Recommendations
Krystal Biotech analyst commentary  »

Krystal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HBAN

Huntington Bancshares

$14.35

-0.02 (-0.14%)

11:50
10/15/18
10/15
11:50
10/15/18
11:50
Options
Huntington Bancshares attracts call buyers »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

11:50
10/15/18
10/15
11:50
10/15/18
11:50
General news
Treasury's $84 B 3- and 6-month bill sales were mixed, but generally lackluster »

Treasury's $84 B 3-…

OXY

Occidental Petroleum

$73.69

-3.24 (-4.21%)

11:48
10/15/18
10/15
11:48
10/15/18
11:48
Hot Stocks
Occidental confirms it will no longer pursue contract extension for ISND »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CENX

Century Aluminum

$10.30

0.14 (1.38%)

11:45
10/15/18
10/15
11:45
10/15/18
11:45
Options
Century Aluminum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

11:45
10/15/18
10/15
11:45
10/15/18
11:45
General news
Former Fed Chair Yellen said 3% growth is great »

Former Fed Chair Yellen…

DUK

Duke Energy

$80.57

0.6 (0.75%)

11:42
10/15/18
10/15
11:42
10/15/18
11:42
Hot Stocks
Duke Energy announces plans for new renewable energy program in South Carolina »

Duke Energy has proposed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 11

    Nov

  • 11

    Nov

ENDP

Endo

$17.62

0.11 (0.63%)

11:35
10/15/18
10/15
11:35
10/15/18
11:35
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

11:34
10/15/18
10/15
11:34
10/15/18
11:34
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:34
10/15/18
10/15
11:34
10/15/18
11:34
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

LTHM

Livent

$16.11

-0.14 (-0.86%)

11:31
10/15/18
10/15
11:31
10/15/18
11:31
Initiation
Livent initiated  »

Livent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PX

Praxair

$158.82

2.62 (1.68%)

, LNEGY

Linde

$0.00

(0.00%)

11:27
10/15/18
10/15
11:27
10/15/18
11:27
Hot Stocks
Linde, Praxair announce squeeze-out of remaining Linde shareholders »

Linde (LNEGY) and Praxair…

PX

Praxair

$158.82

2.62 (1.68%)

LNEGY

Linde

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$73.76

-0.73 (-0.98%)

11:25
10/15/18
10/15
11:25
10/15/18
11:25
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

S

Sprint

$6.35

-0.04 (-0.63%)

11:20
10/15/18
10/15
11:20
10/15/18
11:20
Options
Size ratio spread in Sprint »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

11:20
10/15/18
10/15
11:20
10/15/18
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$14.29

-0.08 (-0.56%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
Technical Take: Huntington Bancshares breaks support »

The shares are down 0.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

PAR

PAR Technology

$20.31

-0.69 (-3.29%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Hot Stocks
Voss Capital supports ADW's call for PAR Technology board to pursue alternatives »

Voss Capital, LLC, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$59.01

-0.67 (-1.12%)

11:15
10/15/18
10/15
11:15
10/15/18
11:15
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:13
10/15/18
10/15
11:13
10/15/18
11:13
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:10
10/15/18
10/15
11:10
10/15/18
11:10
General news
Treasury announced a $25 B 8-week bill for the inaugural sale Tuesday »

Treasury announced a $25…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.